Literature DB >> 10386474

Quebec randomized controlled trial on prostate cancer screening shows no evidence for mortality reduction.

R Boer, F H Schröder.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10386474     DOI: 10.1002/(sici)1097-0045(19990701)40:2<130::aid-pros9>3.0.co;2-x

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


× No keyword cloud information.
  8 in total

1.  Does PSA screening reduce prostate cancer mortality?

Authors:  André N Vis
Journal:  CMAJ       Date:  2002-03-05       Impact factor: 8.262

2.  Cost-effectiveness analysis of prostate cancer screening.

Authors:  C Hamashima; K Yoshida
Journal:  Environ Health Prev Med       Date:  2000-10       Impact factor: 3.674

3.  PSA screening and prostate cancer mortality.

Authors:  Linda Perron; Lynne Moore; Isabelle Bairati; Paul-Marie Bernard; François Meyer
Journal:  CMAJ       Date:  2002-03-05       Impact factor: 8.262

Review 4.  Current status of PSA screening. Early detection of prostate cancer.

Authors:  Tom Pickles
Journal:  Can Fam Physician       Date:  2004-01       Impact factor: 3.275

5.  Trends in prostate cancer incidence and mortality: an analysis of mortality change by screening intensity.

Authors:  Andrew J Coldman; Norman Phillips; Thomas A Pickles
Journal:  CMAJ       Date:  2003-01-07       Impact factor: 8.262

6.  The routine use of prostate-specific antigen for early detection of cancer prostate in India: Is it justified?

Authors:  Deepak Dubey
Journal:  Indian J Urol       Date:  2009-04

7.  Use of Biomarkers in Screening for Cancer.

Authors:  Michael J Duffy
Journal:  EJIFCC       Date:  2010-03-25

Review 8.  The Clinical Efficacy of Prostate Cancer Screening in Worldwide and Iran: Narrative Review.

Authors:  Shima Shahyad; Seyed Hassan Saadat; Seyed-Mostafa Hosseini-Zijoud
Journal:  World J Oncol       Date:  2018-03-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.